The question of how to assess whether there is damage to a nerve fiber is important because the myth of a "pinched nerve" causing localized pain in the neck, back, or shoulder is extremely popular in conservative treatments such as chiropractic care, physiotherapy, etc. A "pinched nerve" cannot be equated with a damaged nerve that would be compressed by an invasive spinal injury, such as a herniated disc (the most common source of invasive injury), progressive degenerative osteoarthritis between the vertebrae, a tumor, or an edema pocket. These conditions should lead to primary functional losses in the nerve functions, such as sensory loss, reflex changes, and muscle weakness. Therefore, the method to detect nerve damage, beyond a patient struggling to bear weight or hold objects with the affected limb, or even experiencing tingling along a specific nerve pathway, is when the patient does not respond to osteotendinous reflexes (tested with the reflex hammer) and when isolated muscle strength tests show weakness in a muscle group affected by one or more nerve roots. At this point, we have enough clinical evidence to justify further medical investigations, including an MRI, to confirm the invasive injury and establish an appropriate treatment protocol, whether conservative or more invasive, to reduce symptom severity. Furthermore, it is extremely important to understand that without neurological impairment, as mentioned earlier, even if a herniated disc or degenerative processes are found in the spine, one should not mistakenly associate these findings with pain. Studies have shown clearly that degenerative processes in the spine, shoulders, knees, and hips can be found incidentally in healthy individuals without any related symptoms.
Neurologists commonly assess nerve damage using Electromyography (EMG) and Nerve Conduction Studies (NCS). EMG involves inserting a needle electrode into muscles to record electrical activity, revealing any abnormalities that may indicate nerve issues. NCS measures the conduction speed of nerves, providing essential information about nerve function and potential damage. Together, these tests help diagnose nerve-related disorders effectively.
As the CEO of Zaleaf, I've always emphasized the importance of incorporating scientific insights into product development. In the cannabinoid industry, we often draw parallels with medical practices when evaluating the effectiveness of different formulations. For instance, to check for nerve damage, a neurologist might use Electromyography (EMG), which measures electrical activity in muscles. This is similar to how we use third-party testing to validate the functionality of our products by examining bioactive compounds' interaction within the human body. In developing our THCA and CBD formulations, we've relied on studies that explore the neuroprotective properties of cannabinoids, akin to how neurologists assess nerve integrity through diverse diagnostic techniques. For example, our focus on THCA's potential benefits is founded on research suggesting its positive effects on neurological disorders, much like how neurologists might apply specific methodologies to diagnose and treat nerve damage. Ensuring product quality and effectiveness is central to Zaleaf's approach, mirroring the precise evaluations in medical diagnostics. Being proactive and utilizing advanced testing not only improves our products but builds trust with our customer base, drawing from the rigorous standards that exist in medical assessments.